Objective.--The bcl-2 protein has the functional role of blocking apoptosis
, ie, programmed cell death. This protein is widely expressed in the develo
ping central and peripheral nervous systems. The purpose of this study was
to map bcl-2 expression in the human enteric nervous system, as this has no
t previously been done.
Methods.--Rectal specimens were obtained at autopsy of 13 fetuses at 13 to
31 weeks of gestation. Normal colon was also obtained from 5 children and 2
adults, and, in addition, ganglionic and aganglionic bowel resected in 11
patients with Hirschsprung disease was examined. Specimens were fixed in fo
rmalin, embedded in paraffin, and analyzed with immunohistochemical methods
, using antibodies raised against bcl-2 and neuron-specific enolase (NSE).
Results.--The bcl-2 protein was expressed in myenteric and submucous gangli
on cells in fetuses, children, and adults. Nerve fibers of the enteric plex
uses that were bcl-2 immunoreactive were few compared with the number of NS
E-immunoreactive nerve fibers. In aganglionic bowel no bcl-2- or NSE-immuno
reactive ganglion cells were revealed. Results of NSE immunohistochemistry
showed clearly stained hypertrophic nerve bundles, known to be of extrinsic
origin, which were only weakly bcl-2 immunoreactive.
Conclusion.--Expression of bcl-2 in enteric ganglion cells of the myenteric
and submucous plexuses is displayed in the fetus and during childhood and
is also retained in adult bowel. Immunohistochemical analysis of bcl-2 prov
ides a good marker for identification of ganglion cells in Hirschsprung dis
ease and may also be valuable for the diagnosis of disorders characterized
by hypoganglionosis or hyperganglionosis.